South San Francisco, CA, United States of America

Prasenjit Kumar Mukherjee

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 11.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Prasenjit Kumar Mukherjee

Introduction

Prasenjit Kumar Mukherjee is a noteworthy inventor based in South San Francisco, California. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds. With a total of three patents to his name, Mukherjee continues to push the boundaries of medical science.

Latest Patents

Mukherjee's latest patents focus on PD-1/PD-L1 inhibitors. These patents disclose compounds of Formula (I) and the methods for using these compounds, both singly and in combination with additional agents and compositions, for the treatment of cancer. His work in this area represents a significant advancement in the options available for cancer therapy, potentially improving outcomes for patients worldwide.

Career Highlights

Currently, Prasenjit Kumar Mukherjee is employed at Gilead Sciences, Inc., a leading biopharmaceutical company known for its innovations in healthcare. His role contributes to the ongoing research efforts that aim to develop effective therapies for critical illnesses. His expertise and dedication have positioned him as a valuable asset within the organization.

Collaborations

Throughout his career, Mukherjee has collaborated with talented colleagues, including Evangelos Aktoudianakis and Aesop Cho. These collaborations foster an environment of innovation and creativity, enabling the development of novel therapeutic solutions. Working alongside accomplished professionals enhances the impact of Mukherjee's research and contributes to the overall success of his projects.

Conclusion

Prasenjit Kumar Mukherjee stands out as an influential inventor in the realm of cancer treatment. His patents related to PD-1/PD-L1 inhibitors demonstrate his commitment to advancing medical science. With a strong career at Gilead Sciences, Inc. and valuable collaborations with esteemed colleagues, Mukherjee continues to inspire innovation and pave the way for future breakthroughs in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…